ETHAN FADALE: Open Payments
NPI 1982290656 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$210 in 10 payments from 8 companies in 2025. Trend: 2023 $236 · 2024 $291 · 2025 $210
Food & beverage: $210
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $42 |
| Esperion Therapeutics, Inc. | 2 | $32 |
| GlaxoSmithKline, LLC. | 1 | $26 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $24 |
| Novo Nordisk Inc | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| Inspire Medical Systems, Inc. | 1 | $20 |
Products named: REPATHA, NEXLETOL, SHINGRIX, LifeVest, Wegovy, FARXIGA, JARDIANCE, INSPIRE.
Industry payments across PA — which companies pay providers there.
